Study S002259

Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg and Bydureon Subcutaneous Injection 2 mg PEN

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01940770
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 1137
Start: 2013-10-18
Primary completion: 2019-11-29
Lead sponsor: AstraZeneca
Conditions: Type 2 Diabetes
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: REGISTRY:EUPAS18608

Registered primary outcomes

Adverse event incidence [3 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.